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 Despite the fact that the phenomenon of hormesis has been known for many years it
is still very much an area of controversy just how useful hormetic treatments are in pre-
venting age-related human diseases and increasing life expectancy. Since there are no data
in humans demonstrating hormesis as an effective anti-ageing strategy we turn to a simple
model organism for insight. In this review we explore what can be predicted about the use-
fulness of hormetic treatments in humans based upon studies conducted in the soil nem-
atode Caenorhabditis elegans. 
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Despite the fact that the phenomenon of hormesis has been known
for almost a century it is still very much an area of controversy just how
useful hormetic treatments are in preventing age-related human diseases
and increasing life expectancy. To date, there is no compelling evidence
that hormesis is an effective approach for human subjects, if the goal is to
achieve not only increased stress resistance but also the increase in
longevity so well documented in model organisms. However, if a narrow-
er definition is taken, there are some promising, indeed provocative, find-
ings in the recent literature suggesting that hormesis could be an impor-
tant strategy for improving human health. For example, Marini et al.
(2008), suggested that using low level activation (‘hormetic levels’) of the
ionotropic glutamate receptor in brain neurons (which triggers endoge-
nous neuronal survival pathways) might be an effective strategy for pre-
venting neurodegenerative disorders as well as a therapeutic tool for aug-
menting cell survival following such damaging, potentially fatal disorders
as stroke (Marini et al. 2008). On a generally similar note, data on mice
indicate that caloric restriction (specifically short term starvation) used as
an activator of hormesis, increases the stress resistance of normal but not
glioma or neuroblastoma cells in vivo to high doses of etoposide, a
chemotherapy drug (Raffaghello et al. 2008). These findings were so
compelling that Johnson et. al. are planning a clinical trial using a gen-
erally similar approach (specifically alternate day dieting) to improve
normal cell and tissue survival in cancer patients scheduled to be treated
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with oxidative damage-producing chemotherapy drugs (Johnson et al.
2009). An even more novel idea for employing hormesis to improve
human health is based, in large part, on the observation that cancer inci-
dence is lower in countries where there is a high infectious disease bur-
den (Deocaris et al. 2005). This observation led to the hypothesis (the
mimotope-hormesis hypothesis) that the lower incidence of cancer is due
to an increased auto-immune response triggered by epitopes (antigens)
associated with the infection that mimic the epitopes found on tumor
cells. This idea of stimulating the immune system as one way that a
hormesis-type prophylaxis can be achieved in humans is also discussed in
a recent paper by Dietert and Piepebrink (Dietert and Piepenbrink
2008). Here, the essential notion is to find strategies, using potential
hormetic agents in utero, to insure, if not augment, the shift (matura-
tion) at birth from a T helper 2 (Th2) cell to a more T helper 1 (Th1)
cell based immune system. It is this shift that is essential to having normal
and long-term immune function later in life (Dietert and Piepenbrink
2008). 
Since there are no data in humans demonstrating hormesis as an
effective anti-ageing strategy that can delay or prevent either the onset of
age-related diseases or aging per se, we turn to simple model organisms for
insight. Many studies have shown that hormesis has anti-aging effects in
model organisms including yeast, worms, flies and, if the effects of dietary
restriction are included, rodents. In particular, the soil nematode C. ele-
gans has been widely used for studying hormesis and its effect on stress
resistance, aging and longevity. In the following discussion, we explore
what can be predicted about the usefulness of hormetic treatments in
humans based upon studies conducted in C. elegans.
There is strong correlation between aging and stress resistance in C.
elegans in that most long lived mutants are also resistant to various forms
of stress (Lithgow and Walker 2002). In some mutants, this increase in
stress resistance stems from increased levels of repair and damage pre-
vention systems. In other mutants, however, the underlying mechanism
remains to be identified. Since transgenic over-expression of enzymes
involved in maintenance and repair, such as hsp-16 (Walker and Lithgow
2003) and hsp-70 (Yokoyama et al. 2002), can lead to increased stress
resistance and lifespan in C. elegans, it is plausible that hormesis simply
acts by stimulating various repair and maintenance pathways. If so, in
principle that approach should also be applicable to humans where aging
is also thought to arise from accumulation of molecular damage. 
WHAT STRESSOR AND DOSE SHOULD ONE USE IN HUMANS?
In C. elegans, a hormetic response following exposure to a mild stress
can be measured by means of increased tolerance to a subsequent stress
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challenge. This phenomenon has been reported for several different
kinds of stress including heat (Lithgow et al. 1994; Yashin et al. 2001;
Cypser and Johnson 2002; Olsen et al. 2006), oxidative stress (Cypser and
Johnson 2002), ionizing radiation (Johnson and Hartman 1988), starva-
tion (Kaeberlein et al. 2006; Honjoh et al. 2009) as well as treatment with
various different chemicals and synthetic compounds (Melov et al. 2000;
Wu et al. 2002; Petrascheck et al. 2007). It is clear, therefore, that there are
a number of potential hormesis ‘inducers’ (‘stressors) to choose from.
However, common for all these treatments is the importance of selecting
the optimal dose since all treatments are toxic if either the dose or the
length of exposure exceeds a critical value. So choosing the right dose is
critical but that is by no means a trivial task. 
Despite the very controlled environment under which nematodes are
kept in the laboratory, as well as the fact that the population is isogenic,
it is still challenging to find a dose that is consistently hormetic. The lit-
erature has many examples of identical hormesis experiments giving dif-
ferent results. Sometimes a treatment is beneficial, sometimes the same
treatment has no effect, and in the worst cases the exact same treatment
can in fact have a negative effect. Moreover, a proper biomarker for a suc-
cessful hormetic treatment has not been identified; something that would
be absolutely essential for monitoring the effects of hormesis in humans.
Not only do most humans have unique genetic identities but, as a species,
we are also exposed to very different levels of natural hormetic ‘stressors’
including variations in diet, climate, pollution, health status etc. On top
of this (and in large part in response to the latter), there are epigenetic
modifications that vary from individual-to-invidual resulting downstream
in differences in gene expression and phenotype. Consequently, it seems,
that like the personalized medicine currently being discussed, hormetic
treatment would have to be designed to fit each individual. 
WHEN SHOULD A HORMETIC TREATMENT BE GIVEN?
Provided that the issue of dose is resolved, other aspects need consid-
eration too. Particularly, the time of treatment could be critical. In C. ele-
gans a single hormetic treatment given early in life (1 day of adulthood)
is sufficient to increase lifespan (Lithgow et al. 1995; Olsen et al. 2006).
Although heat treatments given repeatedly throughout life do increase
the lifespan a little further than a single treatment the gain is rather mod-
est (Olsen et al. 2006). Moreover, while treatment in late life does elicit
the induction of chaperones, it does not significantly increase lifespan
(Olsen et al. 2006). In terms of humans, a single hormetic treatment
given early in life would appear to be the most appealing approach.
However, most, if not all, hormetic treatments in C. elegans severely com-
promise the fertility of the treated animal; making, by extension, early
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treatments a much less attractive approach in humans. Little is known
about the persistence of the hormesis into the next generation, but our
data suggest that the hormetic effect may pass through multiple genera-
tions and have severe effects on both the fertility and fecundity of proge-
ny (unpublished results). Therefore, for now, the only feasible treatment
time in humans appears to be in the post-reproductive period. Clearly,
much more research needs to be done in simple organisms to establish if
late treatments have any beneficial effects before one can even start to
predict if humans will benefit from such a treatment strategy. 
IS HORMESIS A DEAD END?
The evidence, to date makes it clear that it is not yet possible to devise
an evidence-based hormesis treatment for humans based upon the find-
ings from small animal models. Does this mean that work on hormesis is
at a dead end and that the studies in simple model organisms are not
worth while continuing? We think not. Only by understanding the under-
lying mechanisms of a successful hormetic treatment in these simple sys-
tems can we start translating the findings to humans. Because of the find-
ings on, for example C. elegans, we have a much better understanding of
the molecular mechanisms activated by hormetic treatments such as mild
heat treatment (Lithgow et al. 1994; Yashin et al. 2001; Cypser and
Johnson 2002; Olsen et al. 2006) or short term starvation (Honjoh et al.
2009). Such studies are very important because in order to shift horme-
sis from current status as an interesting research paradigm to a treatment
strategy, we need a much better understanding of the mechanistic, molec-
ular basis of homesis. We also need a way of measuring the intrinsic
molecular stress levels of each individual. The latter is likely to prove par-
ticularly challenging because of the strong possibility that there will be tis-
sue and/or organ specific differences in response to treatment even with-
in the same individual. Thus, in terms of drug treatment, one could imag-
ine developing tissue specific therapies but that requires a way of meas-
uring the intrinsic stress level of individual tissues and organs. It is not
currently feasible to do this. The dangers inherent in using too high a
dose of any given hormetic treatment are self-evident and remain a major
obstacle when considering treating normal healthy individuals. Is seems
much more likely that hormetic therapy will become popular as treat-
ment when used as an adjunct to other treatment strategies for serious ill-
nesses. For example, as in the previously mentioned study, dietary restric-
tion (starvation) markedly increased the effectiveness of chemotherapy
in mice (Longo et al. 2008). 
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